Epigenomics AG Reports Results for the Financial Year Ended 31 December 2012
3/21/2013 12:42:05 PM
More...
|
Predictive Biosciences Launches Prostate Cancer Test Based on Epigenomics AG's DNA Methylation Marker
1/29/2013 10:37:57 AM
More...
|
Epigenomics AG Announces First Half 2012 Financial Results and Reports Operational Highlights
8/8/2012 11:25:20 AM
More...
|
Epigenomics, Inc. Cutting Jobs, Moving East
8/11/2011 8:19:06 AM
More...
|
Noel Doheny Appointed as New CEO of Epigenomics, Inc.
4/20/2011 7:06:51 AM
More...
|
Epigenomics, Inc. Appoints Thomas Taapken as New CFO, Effective April 1, 2011
1/11/2011 9:58:20 AM
More...
|
Epigenomics AG And Roche (RHHBY) Diagnostics Extend R&D Collaboration Agreement
10/19/2005 5:13:08 PM
More...
|
Epigenomics AG Presents Positive Prognostic Biomarker Data From Studies In Prostate And Breast Cancer At American Association for Cancer Research
10/19/2005 5:13:02 PM
More...
|
Epigenomics AG And Academic Partners Receive BMBF Grant To Develop Novel Techniques For Early Cancer Detection Based On DNA-Methylation
10/19/2005 5:11:04 PM
More...
|
QIAGEN (QGENF) And Epigenomics AG Enter Into Strategic Collaboration In DNA Methylation
10/19/2005 5:10:41 PM
More...
|
|